Lunt Capital Management’s Health Catalyst HCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$22K Hold
17,337
0.01% 97
2025
Q4
$41.4K Hold
17,337
0.02% 98
2025
Q3
$49.4K Hold
17,337
0.02% 93
2025
Q2
$65.4K Hold
17,337
0.03% 90
2025
Q1
$78.5K Hold
17,337
0.03% 86
2024
Q4
$123K Hold
17,337
0.05% 82
2024
Q3
$141K Hold
17,337
0.07% 90
2024
Q2
$111K Hold
17,337
0.05% 88
2024
Q1
$131K Hold
17,337
0.06% 88
2023
Q4
$161K Hold
17,337
0.08% 84
2023
Q3
$175K Hold
17,337
0.09% 76
2023
Q2
$217K Buy
+17,337
New +$206K 0.12% 76

Other funds holding HCAT

Lunt Capital Management's HCAT Position: Q1 2026 in Review

Lunt Capital Management held its Health Catalyst (HCAT) position steady in Q1 2026 at 17,337 shares worth $22K. The position accounts for 0.01% of the portfolio, ranked #97.

Lunt Capital Management first reported a position in HCAT in Q2 2023 and has held it in 12 quarters since. The position peaked at $217K in Q2 2023. 130 funds tracked by Wall St. Rank hold HCAT as of Q1 2026.

  • Lunt Capital Management held 17,337 shares of Health Catalyst worth $22K as of Q1 2026.
  • Lunt Capital Management left its Health Catalyst share count unchanged in Q1 2026.
  • Health Catalyst made up 0.01% of Lunt Capital Management's portfolio in Q1 2026, its #97 holding.
  • Lunt Capital Management first reported a position in Health Catalyst in Q2 2023 and has held it in 12 quarters since.
  • Lunt Capital Management's Health Catalyst position peaked at $217K in Q2 2023.
  • 130 funds tracked by Wall St. Rank held Health Catalyst as of Q1 2026.

Based on Lunt Capital Management's 13F filing for Q1 2026, filed 13 May 2026.